Rhein kills Actinobacillus pleuropneumoniae, reduces biofilm formation, and effectively treats bacterial lung infections in mice.

IF 2.4 4区 医学 Q3 MICROBIOLOGY Journal of medical microbiology Pub Date : 2024-04-01 DOI:10.1099/jmm.0.001826
Haifeng Ding, Yilin Bai, Weiyu Luo, Hao Li, Chunling Zhu, Xueqin Zhao, Huarun Sun, Yuliang Wen, Wei Zhang, Shouping Zhang, Bo Wen, Ruibiao Wang, Longfei Zhang, Xuehan Liu, Jiyuan Shen, Jianhe Hu, Lei Wang, Yueyu Bai, Chengshui Liao, Yundi Wu, Xilong Wu, Ke Ding
{"title":"Rhein kills Actinobacillus pleuropneumoniae, reduces biofilm formation, and effectively treats bacterial lung infections in mice.","authors":"Haifeng Ding, Yilin Bai, Weiyu Luo, Hao Li, Chunling Zhu, Xueqin Zhao, Huarun Sun, Yuliang Wen, Wei Zhang, Shouping Zhang, Bo Wen, Ruibiao Wang, Longfei Zhang, Xuehan Liu, Jiyuan Shen, Jianhe Hu, Lei Wang, Yueyu Bai, Chengshui Liao, Yundi Wu, Xilong Wu, Ke Ding","doi":"10.1099/jmm.0.001826","DOIUrl":null,"url":null,"abstract":"Background. Actinobacillus pleuropneumoniae, a member of the Pasteurellaceae family, is known for its highly infectious nature and is the primary causative agent of infectious pleuropneumonia in pigs. This disease poses a considerable threat to the global pig industry and leads to substantial economic losses due to reduced productivity, increased mortality rates, and the need for extensive veterinary care and treatment. Due to the emergence of multi-drug-resistant strains, Chinese herbal medicine is considered one of the best alternatives to antibiotics due to its unique mechanism of action and other properties. As a type of Chinese herbal medicine, Rhein has the advantages of a wide antibacterial spectrum and is less likely to develop drug resistance, which can perfectly solve the limitations of current antibacterial treatments.Methods. The killing effect of Rhein on A. pleuropneumoniae was detected by fluorescence quantification of differential expression changes of key genes, and scanning electron microscopy was used to observe the changes in A. pleuropneumoniae status after Rhein treatment. Establishing a mouse model to observe the treatment of Rhein after A. pleuropneumoniae infection.Results. Here, in this study, we found that Rhein had a good killing effect on A. pleuropneumoniae and that the MIC was 25 µg ml-1. After 3 h of action, Rhein (4×MIC) completely kills A. pleuropneumoniae and Rhein has good stability. In addition, the treatment with Rhein (1×MIC) significantly reduced the formation of bacterial biofilms. Therapeutic evaluation in a murine model showed that Rhein protects mice from A. pleuropneumoniae and relieves lung inflammation. Quantitative RT-PCR (Quantitative reverse transcription polymerase chain reaction is a molecular biology technique that combines both reverse transcription and polymerase chain reaction methods to quantitatively detect the amount of a specific RNA molecule) results showed that Rhein treatment significantly downregulated the expression of the IL-18 (Interleukin refers to a class of cytokines produced by white blood cells), TNF-α, p65 and p38 genes. Along with the downregulation of genes such as IL-18, it means that Rhein has an inhibitory effect on the expression of these genes, thereby reducing the activation of inflammatory cells and the production of inflammatory mediators. This helps reduce inflammation and protects tissue from further damage.Conclusions. This study reports the activity of Rhein against A. pleuropneumoniae and its mechanism, and reveals the ability of Rhein to treat A. pleuropneumoniae infection in mice, laying the foundation for the development of new drugs for bacterial infections.","PeriodicalId":16343,"journal":{"name":"Journal of medical microbiology","volume":null,"pages":null},"PeriodicalIF":2.4000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of medical microbiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1099/jmm.0.001826","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background. Actinobacillus pleuropneumoniae, a member of the Pasteurellaceae family, is known for its highly infectious nature and is the primary causative agent of infectious pleuropneumonia in pigs. This disease poses a considerable threat to the global pig industry and leads to substantial economic losses due to reduced productivity, increased mortality rates, and the need for extensive veterinary care and treatment. Due to the emergence of multi-drug-resistant strains, Chinese herbal medicine is considered one of the best alternatives to antibiotics due to its unique mechanism of action and other properties. As a type of Chinese herbal medicine, Rhein has the advantages of a wide antibacterial spectrum and is less likely to develop drug resistance, which can perfectly solve the limitations of current antibacterial treatments.Methods. The killing effect of Rhein on A. pleuropneumoniae was detected by fluorescence quantification of differential expression changes of key genes, and scanning electron microscopy was used to observe the changes in A. pleuropneumoniae status after Rhein treatment. Establishing a mouse model to observe the treatment of Rhein after A. pleuropneumoniae infection.Results. Here, in this study, we found that Rhein had a good killing effect on A. pleuropneumoniae and that the MIC was 25 µg ml-1. After 3 h of action, Rhein (4×MIC) completely kills A. pleuropneumoniae and Rhein has good stability. In addition, the treatment with Rhein (1×MIC) significantly reduced the formation of bacterial biofilms. Therapeutic evaluation in a murine model showed that Rhein protects mice from A. pleuropneumoniae and relieves lung inflammation. Quantitative RT-PCR (Quantitative reverse transcription polymerase chain reaction is a molecular biology technique that combines both reverse transcription and polymerase chain reaction methods to quantitatively detect the amount of a specific RNA molecule) results showed that Rhein treatment significantly downregulated the expression of the IL-18 (Interleukin refers to a class of cytokines produced by white blood cells), TNF-α, p65 and p38 genes. Along with the downregulation of genes such as IL-18, it means that Rhein has an inhibitory effect on the expression of these genes, thereby reducing the activation of inflammatory cells and the production of inflammatory mediators. This helps reduce inflammation and protects tissue from further damage.Conclusions. This study reports the activity of Rhein against A. pleuropneumoniae and its mechanism, and reveals the ability of Rhein to treat A. pleuropneumoniae infection in mice, laying the foundation for the development of new drugs for bacterial infections.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Rhein 可杀死胸膜肺炎放线杆菌,减少生物膜的形成,有效治疗小鼠肺部细菌感染。
背景。胸膜肺炎放线杆菌属于巴斯德氏菌科,以其高度传染性而闻名,是猪传染性胸膜肺炎的主要致病菌。这种疾病对全球养猪业构成了相当大的威胁,由于生产率降低、死亡率上升以及需要大量兽医护理和治疗,导致了巨大的经济损失。由于多种抗药性菌株的出现,中草药因其独特的作用机制和其他特性,被认为是抗生素的最佳替代品之一。大黄作为一种中药材,具有抗菌谱广、不易产生耐药性等优点,完全可以解决目前抗菌治疗的局限性。通过荧光定量分析关键基因的差异表达变化,检测大黄对胸膜肺炎甲菌的杀灭作用,并用扫描电镜观察大黄治疗后胸膜肺炎甲菌状态的变化。结果。在本研究中,我们发现大黄对胸膜肺炎甲菌有很好的杀灭作用,其 MIC 为 25 µg ml-1。作用 3 小时后,大黄(4×MIC)可完全杀死胸膜肺炎甲菌,且大黄具有良好的稳定性。此外,使用 Rhein(1×MIC)治疗可显著减少细菌生物膜的形成。在小鼠模型中进行的治疗评估表明,Rhein 能保护小鼠免受胸膜肺炎甲菌感染,并缓解肺部炎症。定量 RT-PCR(定量反转录聚合酶链式反应,是一种分子生物学技术,结合了反转录和聚合酶链式反应两种方法,用于定量检测特定 RNA 分子的数量)结果显示,大黄霉素能显著下调 IL-18(白细胞介素,指白细胞产生的一类细胞因子)、TNF-α、p65 和 p38 基因的表达。随着 IL-18 等基因的下调,这意味着 Rhein 对这些基因的表达具有抑制作用,从而减少了炎症细胞的激活和炎症介质的产生。这有助于减轻炎症,保护组织免受进一步损伤。本研究报道了大黄霉素对胸膜肺炎甲虫的活性及其机制,揭示了大黄霉素治疗小鼠胸膜肺炎甲虫感染的能力,为开发治疗细菌感染的新药奠定了基础。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of medical microbiology
Journal of medical microbiology 医学-微生物学
CiteScore
5.50
自引率
3.30%
发文量
143
审稿时长
4.5 months
期刊介绍: Journal of Medical Microbiology provides comprehensive coverage of medical, dental and veterinary microbiology, and infectious diseases. We welcome everything from laboratory research to clinical trials, including bacteriology, virology, mycology and parasitology. We publish articles under the following subject categories: Antimicrobial resistance; Clinical microbiology; Disease, diagnosis and diagnostics; Medical mycology; Molecular and microbial epidemiology; Microbiome and microbial ecology in health; One Health; Pathogenesis, virulence and host response; Prevention, therapy and therapeutics
期刊最新文献
Polymyxin combined with Ocimum gratissimum essential oil: one alternative strategy for combating polymyxin-resistant Klebsiella pneumoniae The impact of agar depth on antimicrobial susceptibility testing by disc diffusion Antimicrobial spectrum against wound pathogens and cytotoxicity of star-arranged poly-l-lysine-based antimicrobial peptide polymers Gut microbiota plays a significant role in gout Klebsiella pneumoniae sequence type 147: a high-risk clone increasingly associated with plasmids carrying both resistance and virulence elements
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1